| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 83.79▼ | 83.84▼ | 83.99▼ | 84.94▼ | 84.85▼ |
| MA10 | 83.78▲ | 84.13▼ | 84.14▼ | 84.97▼ | 84.56▼ |
| MA20 | 83.79▼ | 84.29▼ | 84.51▼ | 85.36▼ | 84.75▼ |
| MA50 | 84.10▼ | 84.98▼ | 85.23▼ | 83.72▲ | 78.98▲ |
| MA100 | 84.29▼ | 85.21▼ | 85.16▼ | 83.71▲ | 71.47▲ |
| MA200 | 84.78▼ | 85.24▼ | 85.65▼ | 80.07▲ | 64.80▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.020▲ | -0.026▼ | -0.055▼ | -0.258▼ | -0.391▼ |
| RSI | 42.810▼ | 37.072▼ | 33.644▼ | 44.906▼ | 52.379▲ |
| STOCH | 53.087 | 16.866▼ | 30.921 | 40.671 | 66.925 |
| WILL %R | -65.455 | -87.903▼ | -90.566▼ | -95.690▼ | -47.564 |
| CCI | -21.328 | -97.546 | -117.803▼ | -140.997▼ | -3.604 |
|
Monday, June 16, 2025 05:00 AM
GLP-1/GIP receptor co-agonist designed to be highly potent and for once-monthly administration based on MBX’s novel PEP™ platform technology Phase 1 trial of MBX 4291 is expected to initiate in Q3 ...
|
|
Tuesday, June 10, 2025 05:00 AM
MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and ...
|
|
Monday, June 09, 2025 01:30 PM
Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in a fireside chat at the Oppenheimer 25th Annual Consumer Growth and E-Commerce Conference virtually on Wednesday ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/06/25 | 84.06 | 84.88 | 83.64 | 83.79 | 80,563 |
| 13/06/25 | 83.94 | 84.75 | 83.805 | 83.97 | 222,224 |
| 12/06/25 | 84.83 | 85.57 | 84.60 | 85.14 | 278,537 |
| 11/06/25 | 86.57 | 87.12 | 85.08 | 85.12 | 302,080 |
| 10/06/25 | 86.31 | 87.06 | 86.18 | 86.67 | 159,871 |
| 09/06/25 | 85.18 | 85.96 | 83.97 | 85.68 | 240,067 |
| 06/06/25 | 85.50 | 85.50 | 84.45 | 85.06 | 189,224 |
| 05/06/25 | 84.79 | 84.985 | 84.08 | 84.62 | 283,545 |
| 04/06/25 | 84.87 | 85.83 | 84.51 | 84.79 | 369,346 |
| 03/06/25 | 85.62 | 85.81 | 84.15 | 84.87 | 250,200 |
|
|
||||
|
|
||||
|
|